- Home
- ZNTL vs NPCT Comparison
ZNTL vs NPCT Comparison
Compare ZNTL & NPCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$4.11
Company Overview
Basic Information| Metric | ZNTL | NPCT |
|---|---|---|
| Founded | 2014 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 289.0M | 286.7M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ZNTL | NPCT |
|---|---|---|
| Price | $4.11 | $9.83 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $6.60 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 117.1K |
| Earning Date | 05-07-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.82% |
| EPS Growth | ★ 18.03 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.21 | $9.65 |
| 52 Week High | $6.95 | $11.12 |
Technical Indicators
Market Signals| Indicator | ZNTL | NPCT |
|---|---|---|
| Relative Strength Index (RSI) | 41.97 | 49.92 |
| Support Level | $3.53 | $9.80 |
| Resistance Level | $4.23 | $9.89 |
| Average True Range (ATR) | 0.35 | 0.08 |
| MACD | -0.09 | 0.02 |
| Stochastic Oscillator | 13.60 | 70.86 |
Price Performance
Historical Comparison ZNTL
NPCT
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
About NPCT Nuveen Core Plus Impact Fund of Beneficial Interest
Nuveen Core Plus Impact Fund is an organized, diversified, closed-end management investment company. The Fund's investment objective is to provide a high level of current income.